Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1681-15-8 | MDL No. : | MFCD00137826 |
Formula : | C5H3ClN4 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | JBMBVWROWJGFMG-UHFFFAOYSA-N |
M.W : | 154.56 | Pubchem ID : | 519314 |
Synonyms : |
|
Num. heavy atoms : | 10 |
Num. arom. heavy atoms : | 9 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 36.69 |
TPSA : | 54.46 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.49 cm/s |
Log Po/w (iLOGP) : | 1.07 |
Log Po/w (XLOGP3) : | 1.06 |
Log Po/w (WLOGP) : | 1.01 |
Log Po/w (MLOGP) : | -0.02 |
Log Po/w (SILICOS-IT) : | 1.82 |
Consensus Log Po/w : | 0.99 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.13 |
Solubility : | 1.14 mg/ml ; 0.00738 mol/l |
Class : | Soluble |
Log S (Ali) : | -1.79 |
Solubility : | 2.48 mg/ml ; 0.016 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -2.77 |
Solubility : | 0.264 mg/ml ; 0.00171 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.56 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 7013-21-0 ]
2-Chloro-9-methyl-9H-purin-6-amine
Similarity: 0.86
[ 7139-02-8 ]
2,6-Dichloro-4,8-di(piperidin-1-yl)pyrimido[5,4-d]pyrimidine
Similarity: 0.83
[ 2382-10-7 ]
2,6-Dichloro-9-methyl-9H-purine
Similarity: 0.82
[ 14631-08-4 ]
2-Chloropyrimidine-4,5-diamine
Similarity: 0.81
[ 63211-98-3 ]
2-Chloro-6-methylpyrimidine-4,5-diamine
Similarity: 0.81
[ 7013-21-0 ]
2-Chloro-9-methyl-9H-purin-6-amine
Similarity: 0.86
[ 2382-10-7 ]
2,6-Dichloro-9-methyl-9H-purine
Similarity: 0.82